HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oh Woong Kwon Selected Research

Ischemia

9/2008Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.
7/2008Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oh Woong Kwon Research Topics

Disease

10Macular Degeneration (Age-Related Maculopathy)
08/2016 - 05/2004
10Macular Edema
04/2016 - 07/2008
7Diabetic Retinopathy (Retinopathy, Diabetic)
06/2015 - 02/2006
7Choroidal Neovascularization
05/2010 - 10/2003
6Polypoidal Choroidal Vasculopathy
02/2021 - 05/2004
3Retinal Detachment (Retinal Detachments)
01/2019 - 08/2002
3Cataract (Cataracts)
08/2013 - 01/2009
2Central Serous Chorioretinopathy
01/2019 - 01/2010
2Microaneurysm
04/2015 - 06/2012
2Stroke (Strokes)
06/2014 - 11/2008
2Infections
09/2012 - 12/2008
2Disease Progression
09/2010 - 12/2008
2Ischemia
09/2008 - 07/2008
1Aphakia
11/2021
1Polyps
02/2019
1Retinitis Pigmentosa (Pigmentary Retinopathy)
08/2017
1Epiretinal Membrane (Epiretinal Membranes)
08/2017
1Hemorrhage
06/2016
1Vascular Remodeling
01/2016
1Pain (Aches)
10/2015
1Inflammation (Inflammations)
10/2015
1Edema (Dropsy)
04/2015
1Retinal Perforations
01/2015
1Cicatrix (Scar)
10/2014
1Toxocariasis
10/2014
1Atherosclerosis
06/2014
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2013
1Neoplasms (Cancer)
01/2010
1Osteoma
02/2009
1Hepatitis B
12/2008
1Chorioretinitis
12/2008
1Hypertension (High Blood Pressure)
11/2008
1Retinal Vein Occlusion
09/2008
1Uveitis
01/2008
1Type 2 Diabetes Mellitus (MODY)
01/2008
1Necrosis
03/2007
1Herpes Simplex
03/2007
1Retinitis
03/2007
1Vitreous Hemorrhage
03/2007
1Herpes Zoster
03/2007
1Acquired Immunodeficiency Syndrome (AIDS)
03/2007
1Retinoschisis (Retinoschisis, Juvenile)
01/2007
1Congenital Abnormalities (Deformity)
01/2006
1Capsule Opacification
08/2004
1Diplopia (Double Vision)
06/2004
1Pars Planitis
06/2004
1Histoplasmosis
05/2004
1Papilledema
10/2003
1Burns
08/2002
1Proliferative Vitreoretinopathy
08/2002

Drug/Important Bio-Agent (IBA)

12Bevacizumab (Avastin)FDA Link
08/2016 - 07/2008
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2019 - 01/2009
9Retinaldehyde (Retinal)IBA
10/2014 - 08/2002
7Fluorescein (Funduscein)FDA LinkGeneric
10/2014 - 10/2003
51-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2013 - 05/2004
4Ranibizumab (Lucentis)FDA Link
08/2016 - 08/2013
4CytokinesIBA
05/2010 - 01/2008
3afliberceptIBA
02/2021 - 01/2015
3SteroidsIBA
10/2015 - 01/2008
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2010 - 10/2003
2Triamcinolone (Aristocort)FDA Link
10/2014 - 01/2009
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2009 - 12/2008
2Triglycerides (Triacylglycerol)IBA
12/2008 - 11/2008
2LDL Lipoproteins (beta Lipoproteins)IBA
11/2008 - 01/2008
1SuspensionsIBA
11/2021
1TenecteplaseFDA Link
06/2016
1Gabapentin (Neurontin)FDA LinkGeneric
04/2016
1DisintegrinsIBA
01/2016
1Oxygen (Dioxygen)IBA
01/2016
1glucuronyl glucosamine glycan sulfate (sulodexide)IBA
06/2015
1Immunoglobulin G (IgG)IBA
10/2014
1Albendazole (Albenza)FDA Link
10/2014
1danaparoid (Orgaran)FDA Link
06/2014
1Silicone OilsIBA
01/2010
1Indicators and Reagents (Reagents)IBA
10/2009
1Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2008
1HDL LipoproteinsIBA
12/2008
1LipidsIBA
11/2008
1Complement Factor H (Factor H)IBA
05/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008
1oxidized low density lipoproteinIBA
01/2008
1Interleukin-6 (Interleukin 6)IBA
01/2008
1Fructose-Bisphosphate Aldolase (Aldolase)IBA
02/2006
1AutoantibodiesIBA
02/2006
1Proteins (Proteins, Gene)FDA Link
02/2006
1MiragelIBA
06/2004
1Verteporfin (Visudyne)FDA Link
05/2004

Therapy/Procedure

8Vitrectomy
11/2021 - 08/2004
7Intravitreal Injections
08/2016 - 10/2008
5Lasers (Laser)
01/2019 - 08/2002
5Injections
10/2015 - 07/2008
4Photochemotherapy (Photodynamic Therapy)
08/2013 - 05/2004
3Therapeutics
02/2021 - 07/2008
3Light Coagulation
04/2015 - 08/2002
2Aftercare (After-Treatment)
08/2013 - 07/2008
1Intraocular Lenses (Intraocular Lens)
11/2021
1Duration of Therapy
01/2019
1Cataract Extraction
08/2004
1Scleral Buckling
08/2002
1Traction
08/2002